Dr. Adrianne Pope

She has a background in science with a Ph.D. in genetics and over 27 years’ experience in Assisted Reproductive Technology (ART) and pathology services. She commenced her career in 1986 in Queensland, Australia. ART Launched Adrianne into a varied career around the world having directed a number of ART facilities in Australia and overseas with positions in the USA and Ireland. Adrianne has a vast wealth of experience in dealing with issues related to ART and was very active in the Australian Reproductive Technology Accreditation Committee (RTAC), the peak auditing body, for many years. Her involvement included the coordination and writing of the 2005 RTAC Code of Practice and the 2008 review. Dr. Pope was elected President of the Fertility Society of Australia (FSA) in 2003. In 2005 she was re-elected, thus making her the first FSA president to serve two ter. She has represented the FSA on many government reviews on accreditation and undertaken many submissions relating to legislation and regulation.

Having commenced a professional career as an embryologist in a pioneering area of healthcare, her work led her out of the laboratory and into many varied roles in healthcare management, establishing ART facilities, implementing Quality Management Systems, strategic planning, and business development. This leadership was recognized outside of specific employment positions with numerous career highlights including:

PROFESSIONAL HIGHLIGHTS

  • President of the Fertility Society of Australia (2003—2007)
  • Member of NH MRC Licensing Committee Working Party on Definition of an Embryo (2005)
  • Scientific Representative on Reproductive Technologies Accreditation Committee (RTAC) (2001—2007)
  • Chairperson — Scientists In Reproductive Technology (SIRT) (2001—2003)
  • Director — Fertility Society of Australia (2002—2007)
  • Co-opted supporting committee member of MSAC on Intra Cytoplasmic Sperm Injection (2002—2003)
  • Monash IVF Standards Subcommittee — Secretary (2000—2004)
  • Monash IVF Research Subcommittee (1999—2004)
  • NATA Assessor — 15015189
  • Review Committee RTAC Code of Practice (2004, 2005, 2006 & 2007)
  • Scientific Advisor to Victorian In Vitro Fertilization Treatment Authority (VARTA) (2004—2010)
  • Consultant to Dept. Health & Ageing — Regulation of Organs, Tissue & Reproductive Tissues (2007)
  • RTAC Code of Practice — Technical Expert Committee for the revision of Code (2007—2008)
  • RTAC Auditor — Technical Expert
  • National Pathology Accreditation Advisory Council — Supervision Drafting Committee (2008—2013)

PROFESSIONAL RESPONSIBILITIES

CEO (QLD), Monash IVF

  • Leadership role with responsibilities in business success, establishing new facilities, raising company profile, and managing a $14M budget development and compliance.

Business Development

  • Negotiation with US companies and Australian regulators resulting in access by Australian patients to donated gametes from the USA—an Australian first.

Director of Business Development, Repromed

  • Business growth including implementation of brand awareness marketing strategy.
  • Project leader for due diligence process of a highly successful share sale to a private equity company.
  • Development of new website with external consultants.
  • Integration of a new business in New Zealand.
  • Establishing new facilities.
  • Financial review and development of synergies.

Other Key Positions

  • Operations Manager, Wesley Monash IVF & Monash IVF Regional QLD.
  • Director of Laboratory Services, Monash IVF.
  • Director of Embryology, Monash IVF.
  • Reproductive Biology Supervisor, QLD. Fertility Group.
  • Consultant to Embryology — Human Assisted Reproduction in Ireland.
  • Director of Andrology & In Vitro Fertilization — Hillcrest Fertility Centre, Tulsa, USA.
  • Director of Reproductive Biology — Southern California Fertility Institute, Los Angeles, USA.
  • IVF Scientist — QLD. Fertility Group.